EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Efficacy of Fecal Microbial Transplantation for Improving Symptoms of Irritable Bowel Syndrome - A Pilot Study for Voluntary Participants in Korea

Jung Won Lee, Nayoung Kim iD

The Korean Journal of Gastroenterology · 2024

DOI: 10.4166/kjg.2024.107 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Korean Journal of Gastroenterology, 2024. Verfasst von Jung Won Lee und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Korea. Hauptthemen laut MEDLINE: Irritable Bowel Syndrome, Fecal Microbiota Transplantation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ministry of Trade, Industry and Energy.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Aims: Irritable bowel syndrome (IBS) is a chronic, intractable functional disease. It is inferred that fecal microbiota transplantation (FMT) may have favorable efficacy on IBS by gut microbial modification. The aim of this study was to investigate the efficacy of FMT for improving severity in patients with IBS.

Methods

Patients who voluntarily wanted FMT were consecutively enrolled. The study subjects were classified by subtype of IBS by the ROME IV criteria. The IBS-symptom severity score (IBS-SSS) was used to evaluate the efficacy of FMT. The subjects completed a questionnaire at baseline week 0 and weeks 4, 12, and 24 after FMT. FMT was performed by esophagogastroduodenoscopy using frozen stock stool solution. If the follow-up IBS-SSS achieved less than 75 points, it was defined as remission. Adverse events were also gathered.

Results

Twenty-one subjects were included from October 2023 until July 2024. There were 7 patients with IBS-C, 10 patients with IBS-D, 2 patients with IBS-M, and 2 patients with IBS-U type. The mean SSS of the IBS-D group was 244.0±64.2, which was higher than IBS-C group (192.9±85.4). Alleviations in IBS-SSS after FMT were observed in 19 subjects (19/21, 90.5%) at week 4. At week 12, 71.4% (5/7) in the IBS-C group and 20.0% (2/10) in the IBS-D group achieved remission. The remission states were maintained up to week 24 and no serious adverse events were reported.

Conclusions

FMT might be an effective treatment option for improving symptoms of mild to moderate IBS, especially IBS-C.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Irritable Bowel SyndromeFecal Microbiota TransplantationHumansMaleFemaleAdultMiddle AgedPilot ProjectsSurveys and QuestionnairesRepublic of KoreaSeverity of Illness IndexTreatment OutcomeFeces

Stichwörter der Autor:innen

ConstipationDiarrheaFecal microbiota transplantationGastrointestinal microbiomeIrritable bowel syndrome

Autor:innen und Institutionen

  • Department of Internal Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Korea.
  • Department of Internal Medicine and Research Center for Sex-Gender-Specific Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
  • Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea.

ORCID-Profile: Nayoung Kim

Förderung

  • Ministry of Trade, Industry and Energy

Zitieren

APA

Lee, J. W., & Kim, N. (2024). Efficacy of Fecal Microbial Transplantation for Improving Symptoms of Irritable Bowel Syndrome - A Pilot Study for Voluntary Participants in Korea. The Korean Journal of Gastroenterology. https://doi.org/10.4166/kjg.2024.107

Vancouver

Lee JW, Kim N. Efficacy of Fecal Microbial Transplantation for Improving Symptoms of Irritable Bowel Syndrome - A Pilot Study for Voluntary Participants in Korea. The Korean Journal of Gastroenterology. 2024. doi:10.4166/kjg.2024.107

BibTeX
@article{Lee2024,
  author = {Lee, Jung Won and Kim, Nayoung},
  title = {Efficacy of Fecal Microbial Transplantation for Improving Symptoms of Irritable Bowel Syndrome - A Pilot Study for Voluntary Participants in Korea},
  journal = {The Korean Journal of Gastroenterology},
  year = {2024},
  doi = {10.4166/kjg.2024.107}
}
Kostenlos starten →